Literature DB >> 19921405

Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.

James P Bertram1, Millicent F Rauch, Kaliq Chang, Erin B Lavik.   

Abstract

PURPOSE: Brain-derived neurotrophic factor (BDNF) plays an important role in neuroprotection and repair, but long-term delivery from polymer systems has been challenging. We investigated the role the chemistry of the polymer played in loading and delivery of BDNF via microspheres, which are suitable for minimally invasive administration.
METHODS: We synthesized polymers based on PLGA and PEG to determine what components augmented loading and delivery. We characterized microspheres fabricated from these polymers using a battery of tests, including sizing, in vitro release, and bioactivity of the BDNF using PC12 cells engineered to express the trkB receptor.
RESULTS: We found that a triblock polymer of PLGA, PLL, and PEG led to the delivery of BDNF for periods of time greater than 60 days and that the BDNF delivered was bioactive. The microsphere size was amendable to injection via a 30 gauge needle, allowing minimally invasive delivery.
CONCLUSIONS: PLGA-PLL-PEG leads to greater loading and longer-term delivery of BDNF than PLGA or a blend of the polymers. We hypothesize that the introduction of an amphiphilic PLGA-based polymer increases the interaction of the BDNF with the polymer and leads to release that more closely correlates with the degradation of the polymer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921405     DOI: 10.1007/s11095-009-0009-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  46 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III).

Authors: 
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 3.  Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  Eur J Pharm Biopharm       Date:  2005-04       Impact factor: 5.571

4.  A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo.

Authors:  Millicent C Ford; James P Bertram; Sara Royce Hynes; Michael Michaud; Qi Li; Michael Young; Steven S Segal; Joseph A Madri; Erin B Lavik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

5.  Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres.

Authors:  M S Ward; A Khoobehi; E B Lavik; R Langer; M J Young
Journal:  J Pharm Sci       Date:  2007-03       Impact factor: 3.534

6.  Tissue Engineering Applied to the Retinal Prosthesis: Neurotrophin-Eluting Polymeric Hydrogel Coatings.

Authors:  Jessica O Winter; Mrudula Gokhale; Ralph J Jensen; Stuart F Cogan; Joseph F Rizzo
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2008-04-01       Impact factor: 7.328

7.  Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels.

Authors:  N I Bamber; H Li; X Lu; M Oudega; P Aebischer; X M Xu
Journal:  Eur J Neurosci       Date:  2001-01       Impact factor: 3.386

8.  Cyclodextrin complexation for affinity-based antibiotic delivery.

Authors:  Thimma Reddy Thatiparti; Horst A von Recum
Journal:  Macromol Biosci       Date:  2010-01-11       Impact factor: 4.979

9.  Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.

Authors:  James P Bertram; Steven M Jay; Sara R Hynes; Rebecca Robinson; Jason M Criscione; Erin B Lavik
Journal:  Acta Biomater       Date:  2009-05-04       Impact factor: 8.947

10.  Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system.

Authors:  Matthew D Wood; Gregory H Borschel; Shelly E Sakiyama-Elbert
Journal:  J Biomed Mater Res A       Date:  2009-06-15       Impact factor: 4.396

View more
  18 in total

1.  Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.

Authors:  Tapan Kumar Giri; Chhatrapal Choudhary; Amit Alexander; Hemant Badwaik; Dulal Krishna Tripathi
Journal:  Saudi Pharm J       Date:  2012-05-26       Impact factor: 4.330

Review 2.  Approaches for neural tissue regeneration.

Authors:  Loïc Binan; Abdellah Ajji; Gregory De Crescenzo; Mario Jolicoeur
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

Review 3.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 4.  Neurotrophin strategies for neuroprotection: are they sufficient?

Authors:  Joseph P Steiner; Avindra Nath
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-08       Impact factor: 4.147

Review 5.  Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease.

Authors:  Lucia Caffino; Francesca Mottarlini; Fabio Fumagalli
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

6.  In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival.

Authors:  Luis P B Guerzoni; Valérie Nicolas; Angelina Angelova
Journal:  Pharm Res       Date:  2016-12-19       Impact factor: 4.200

7.  Injectable Neurotrophic Factor Delivery System Supporting Retinal Ganglion Cell Survival and Regeneration Following Optic Nerve Crush.

Authors:  Melissa R Laughter; James R Bardill; David A Ammar; Brisa Pena; David J Calkins; Daewon Park
Journal:  ACS Biomater Sci Eng       Date:  2018-07-23

8.  Porous Silicon Nanoparticles Targeted to the Extracellular Matrix for Therapeutic Protein Delivery in Traumatic Brain Injury.

Authors:  Lauren E Waggoner; Jinyoung Kang; Jonathan M Zuidema; Sanahan Vijayakumar; Alan A Hurtado; Michael J Sailor; Ester J Kwon
Journal:  Bioconjug Chem       Date:  2022-08-26       Impact factor: 6.069

Review 9.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.

Authors:  Bai Lu; Guhan Nagappan; Xiaoming Guan; Pradeep J Nathan; Paul Wren
Journal:  Nat Rev Neurosci       Date:  2013-05-15       Impact factor: 34.870

10.  Nanoformulation of Brain-Derived Neurotrophic Factor with Target Receptor-Triggered-Release in the Central Nervous System.

Authors:  Yuhang Jiang; James M Fay; Chi-Duen Poon; Natasha Vinod; Yuling Zhao; Kristin Bullock; Si Qin; Devika S Manickam; Xiang Yi; William A Banks; Alexander V Kabanov
Journal:  Adv Funct Mater       Date:  2017-12-07       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.